@article {1517170,
	title = {Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature},
	journal = {In Vivo},
	volume = {34},
	number = {3 Suppl},
	year = {2020},
	month = {2020 Jun},
	pages = {1619-1628},
	abstract = {The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China in the city of Wuhan in December of 2019 and since then more than 5,000,000 people have been infected, with approximately 338,000 deaths worldwide. The virus causes the coronavirus disease 2019 (COVID-19), which is characterized by fever, myalgia and cough, with severe acute respiratory syndrome being the most fearsome complication. Nevertheless, the vast majority of cases present mild symptoms or none. Central nervous system and cardiovascular manifestations have been reported. The range of ocular manifestations, either as a result of the infection or as a result of the treatment, has not yet been discussed. In this study, a systematic review of current literature relevant to COVID-19 was performed with focus on modes of transmission, ocular manifestations related to infection and medications, as well as the control of infection in ophthalmic practice.},
	keywords = {Abducens Nerve Diseases, Antiviral Agents, Betacoronavirus, Biomarkers, China, Conjunctival Diseases, Contact Lenses, Coronavirus Infections, Equipment Contamination, Eye Diseases, Humans, Hyperemia, Immunization, Passive, Infectious Disease Transmission, Patient-to-Professional, Keratoconjunctivitis, Lacrimal Apparatus Diseases, Leukocyte Count, Pandemics, Pneumonia, Viral, Retinal Diseases, Retrospective Studies},
	issn = {1791-7549},
	doi = {10.21873/invivo.11952},
	author = {Douglas, Konstantinos Aa and Douglas, Vivian Paraskevi and Moschos, Marilita M}
}
